Mr. Marc-Andre Massue reports

DIAGNOS ANNOUNCES VARIATION IN ONE INSIDER OWNERSHIP

As a result of Diagnos Inc.'s issuance of 8,333,333 common share as part of a private placement of units announced on Sept. 20, 2024, Tristram Coffin ceased to be an insider of the corporation since his ownership dropped below 10 per cent.

Immediately before the issuance of the shares, Mr. Coffin exercised control, directly and indirectly, over 8,180,234 shares of the issuer, representing ownership of 10.04 per cent on an undiluted basis.

The issuance of the shares remains subject to the TSX Venture approval.

About Diagnos Inc.

Diagnos is a publicly traded Canadian corporation with a mission of early detection of critical health issues through the use of advanced image enhancement algorithms which make standard retinal images sharper, clearer and easier to read.